You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sep-363856

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial (SEP-363856, Placebo)

Not yet recruiting
  • Schizophrenia
  • SEP-363856
  • Placebo
  • (no location specified)
Apr 27, 2023

Schizophrenia Trial (SEP-363856)

Not yet recruiting
  • Schizophrenia
  • SEP-363856
  • (no location specified)
Feb 22, 2023

Generalized Anxiety Disorder Trial (SEP-363856, Placebo)

Not yet recruiting
  • Generalized Anxiety Disorder
  • SEP-363856
  • Placebo
  • (no location specified)
Feb 6, 2023

Schizophrenia Trial (SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole))

Not yet recruiting
  • Schizophrenia
  • SEP-363856
  • Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
  • (no location specified)
Sep 13, 2022

MDD Trial in New York (SEP-363856, Placebo)

Recruiting
  • Major Depressive Disorder
  • SEP-363856
  • Placebo
  • New York, New York
    For additional information regarding sites, contact 844-687-8522
Nov 14, 2022

Schizophrenia Trial in United States (SEP-363856)

Recruiting
  • Schizophrenia
  • SEP-363856
  • Culver City, California
  • +14 more
Jan 26, 2023

Schizophrenia Trial (SEP-363856)

Not yet recruiting
  • Schizophrenia
  • SEP-363856
  • (no location specified)
Jul 14, 2022

Schizophrenia Trial in Oakland Park, Marlton (, SEP-363856, metformin)

Completed
  • Schizophrenia
  • placebo
  • +2 more
  • Oakland Park, Florida
  • +1 more
May 31, 2022

Schizophrenia Trial in United States (SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole))

Recruiting
  • Schizophrenia
  • SEP-363856
  • Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
  • Little Rock, Arkansas
  • +6 more
Nov 11, 2022

Schizophrenia Trial in Japan (SEP-363856)

Completed
  • Schizophrenia
  • SEP-363856
  • Konan, Aichi, Japan
  • +7 more
Apr 9, 2022

Schizophrenia Trial in London (SEP-363856)

Recruiting
  • Schizophrenia
  • SEP-363856
  • London, United Kingdom
    King's College London
Oct 3, 2022

Schizophrenia Trial in Japan (SEP-363856)

Recruiting
  • Schizophrenia
  • SEP-363856
  • Konan-shi, Aichi, Japan
  • +46 more
Jul 5, 2022

Schizophrenia Trial in Worldwide (SEP-363856)

Completed
Has Results
  • Schizophrenia
  • SEP-363856
  • Little Rock, Arkansas
  • +29 more
Feb 8, 2022

Schizophrenia Trial in Worldwide (SEP-363856, Placebo - Cap)

Completed
Has Results
  • Schizophrenia
  • SEP-363856
  • Placebo - Cap
  • Little Rock, Arkansas
  • +32 more
Aug 25, 2021

Parkinson Disease Psychosis Trial in United States (SEP-363856, Placebo capsule)

Completed
  • Parkinson Disease Psychosis
  • SEP-363856
  • Placebo capsule
  • Fresno, California
  • +23 more
Aug 2, 2021

Schizophrenia Trial in Headington, Manchester (SEP-363856, Amisulpride, Placebo)

Completed
  • Schizophrenia
  • SEP-363856
  • +2 more
  • Headington, Oxford, United Kingdom
  • +1 more
Feb 22, 2016

Schizophrenia Trial in Glendale, Long Beach (SEP-363856, Placebo, SEP-363856 Open Label)

Completed
  • Schizophrenia
  • SEP-363856
  • +2 more
  • Glendale, California
  • +1 more
Feb 6, 2015

Schizophrenia Trial in Glendale, Long Beach (SEP-363856, Placebo)

Completed
  • Schizophrenia
  • SEP-363856
  • Placebo
  • Glendale, California
  • +1 more
Jul 3, 2014